Table 3.
Baseline (n = 51) | Discharge (n = 47) | 3 Months-FU (n = 43) | ||||
Mean ± SD | Median (IQR) | Mean ± SD | Median (IQR) | Mean ± SD | Median (IQR) | |
Clostridia | ||||||
Fasting, RA | 5.8 ± 0.4 | 5.7 (5.7-5.7) | 5.7 ± 0.1 | 5.7 (5.7-5.7) | 5.8 ± 0.3 | 5.7 (5.7-5.7) |
Fasting, FM | 5.8 ± 0.2 | 5.7 (5.7-5.7) | 5.8 ± 0.2 | 5.7 (5.7-5.7) | 5.7 ± 0.1 | 5.7 (5.7-5.7) |
MD, RA | 5.7 ± 0.1 | 5.7 (5.7-5.7) | 5.7 ± 0.2 | 5.7 (5.7-5.7) | 5.9 ± 0.3 | 5.7 (5.7-5.7) |
MD, FM | 6.0 ± 0.6 | 5.8 (5.6–5.9) | 5.8 ± 0.1 | 5.7 (5.7-5.7) | 5.8 ± 0.2 | 5.7 (5.7-5.7) |
Bidifidobacteria | ||||||
Fasting, RA | 7.7 ± 1.2 | 8.0 (7.0–8.5) | 7.2 ± 1.1 | 7.5 (6.6–8.0) | 7.7 ± 0.9 | 7.9 (7.5–8.0) |
Fasting, FM | 7.6 ± 1.2 | 7.7 (7.0–9.0) | 7.6 ± 1.0 | 7.5 (7.0–8.2) | 8.0 ± 0.9 | 8.0 (7.4–8.5) |
MD, RA | 7.5 ± 1.2 | 8.0 (6.3–8.5) | 8.1 ± 0.9 | 8.2 (7.3–9.0) | 7.9 ± 0.9 | 7.9 (7.3–8.0) |
MD, FM | 7.5 ± 1.0 | 7.5 (7.0–8.0) | 7.4 ± 1.2 | 7.4 (6.5–8.2) | 7.6 ± 1.4 | 7.5 (7.0–9.0) |
Candida | ||||||
Fasting, RA | 2.2 ± 0.7 | 1.7 (1.7–2.6) | 2.4 ± 0.9 | 2.0 (1.7–2.8) | 2.4 ± 1.1 | 2.0 (1.7–2.6) |
Fasting, FM | 2.4 ± 0.9 | 1.7 (1.7–3.0) | 2.6 ± 1.1 | 2.0 (1.7–2.7) | 2.6 ± 1.0 | 2.5 (1.7–2.5) |
MD, RA | 2.4 ± 1.0 | 2.0 (1.7–3.0) | 2.1 ± 0.4 | 1.7 (1.7–2.3) | 2.2 ± 0.7 | 1.7 (1.7–2.6) |
MD, FM | 2.6 ± 0.8 | 2.5 (2.0–3.3) | 2.4 ± 1.1 | 1.7 (1.7–3.2) | 2.8 ± 1.0 | 2.8 (2.0–3.3) |
FU, follow-up; IQR, interquartile range; MD, Mediterranean diet; RA, rheumatoid arthritis; FM, fibromyalgia.